We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Rize Enviro Etf | LSE:LIFE | London | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00525 | 0.11% | 4.7198 | 4.7095 | 4.73 | - | 0 | 16:35:14 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/12/2015 08:58 | Life science is a key chapter in JM's Fast Forward book and also the entire focus in his other book Cracking The Code. The guy is an expert in this field when it comes to spotting opportunities. This is only just starting. | keya5000 | |
31/12/2015 08:58 | Meanwhile back in reality - 4.25p paid (premium) | mikeh30 | |
31/12/2015 08:57 | Harebridge - I'm sure the holders of LIFE, FFWD and WEB are cursing his name right now!Next! | mikeh30 | |
31/12/2015 08:57 | Life sciences will e massive and with Jim melons connections this will be a massive success | gimmetheloot | |
31/12/2015 08:55 | Thanks for that. Now jog on. Bitter individual. | keya5000 | |
31/12/2015 08:54 | FFWD punters will be all over this soon when the investments are announced.FFWD 4p -->20pLIFE 4p-->??? | mikeh30 | |
31/12/2015 08:54 | A word of caution about Jim Mellon. Look at the graph of CNR over the last few years from when he came on board. £2 to 20p. Be very careful where he's involved. | harebridge | |
31/12/2015 08:53 | Key break of 4p is close. If so 5p will come very soon. | keya5000 | |
31/12/2015 08:52 | Only £1.3m cap. | mikeh30 | |
31/12/2015 08:50 | Stupidly cheap when compared to its peers. | someuwin | |
31/12/2015 08:49 | Mike think with some buying at these levels you targets for today are a bit light. | keya5000 | |
31/12/2015 08:48 | Lovely blue sky ahead of us guys. | mikeh30 | |
31/12/2015 08:36 | 4p test this morning. 5p finish with a bit of wind behind us | mikeh30 | |
31/12/2015 08:36 | Still think this could be the vehicle that PulseFlow reverses onto. Given the Mellon connection its not just a wild guess. | keya5000 | |
31/12/2015 08:35 | Life gone blue ;-)) this will make Webis look like a tortoise ;-)) | gimmetheloot | |
31/12/2015 08:35 | Other big rise today on the cards.One to be in I think. | bckttsim | |
31/12/2015 08:34 | Strong like bull | mikeh30 | |
31/12/2015 08:30 | From LSEKiran Mazumdar Shaw: Life science developments to look out for in 2016.These are exciting times for the life sciences sector as it builds on its understanding of the disease at the cellular and genetic level to usher in new and differentiated therapies into the market. Furthermore, biomedical advances are likely to transform global health with early diagnosis and therapeutic intervention for chronic and killer diseases like autoimmune diseases and cancer.The top five scientific developments to be tracked in 2016 are:http://www.busin | bckttsim | |
30/12/2015 22:39 | KEYA - Mellon will know exactly what he's gonna do here. Pulseflow may be part of it.£1m to invest was more than KUL/FFWD started with. Let's see what he can do with it.I want my 10p though. I mentioned 12p in the early days of KUL which was questioned and now look at it. 10p will come here. | mikeh30 | |
30/12/2015 21:59 | 16% of the company's shares traded today. | lr2 | |
30/12/2015 21:59 | Just a thought. But could JM be lining up a RTO here with PulseFlow? | keya5000 | |
30/12/2015 21:50 | You don't get volume like this for nothing ... | nw99 | |
30/12/2015 21:36 | . The Company's focus will be on either building a sizeable investment fund within the Company's chosen sector or on the acquisition of a single company or business in this sector, constituting a reverse takeover under the AIM Rules for Companies. | mikeh30 | |
30/12/2015 19:02 | Kiran Mazumdar Shaw: Life science developments to look out for in 2016. | lr2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions